https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.760698/full
Frontiers | Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and...
Finafloxacin is a novel fluoroquinolone with optimal antibacterial activity in low pH environments, therefore offering a therapeutic advantage over some trad...
signs of infectiona novel